Switzerland Shifted Into High-Value Manufacturing

Peter Zeihan traces Switzerland’s move to luxury goods and biotech, especially pharmaceuticals, to offset currency pressures.

Play episode from 03:56

Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!